[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cisplatin-adverse-reaction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cisplatin-adverse-reaction":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100486225","late-subclinical-cardiovascular-disease-in-testicular-cancer-survivors-100486225",false,"NCT05611307","Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors","Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant","Inclusion Criteria\n\n* Patients \\>18 years of age\n* Patients will be recruited only if cancer-free at clinical evaluation time.\n* For the cases a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies (CBCT group, Arm 2)\n* For the cases with a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies and underwent BMT for relapsed refractory disease (CBCT \\& BMT group, Arm 3).\n* For the comparison cohort, biopsy-proven TC patients who had surgery for or surveillance of their testicular cancer and never received CBCTCBCT or BMT (surgical\u002Fsurveillance, Arm 1)\n\nExclusion Criteria\n\n* Prior known myocardial infarction (MI), atherosclerotic cardiovascular disease (ASCVD)\n* Significant renal disease (GFR\\\u003C40)\n* Allergy to iodinated contrast\n* Antecedent chemotherapy for another primary cancer.","MALE","18 Years","99 Years",{"count":20,"type":21},150,"ESTIMATED","OBSERVATIONAL","Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant",[25,26,27,28,29,30,31,32],"Testicular Cancer","Survivorship","ASCVD","Coronary Artery Disease","Lipid Disorder","Hypogonadism, Male","Cisplatin Adverse Reaction","Bone Marrow Transplant Complications","RECRUITING","2026-07-23",{"date":36,"type":37},"2026-07-27","ACTUAL",{"date":39,"type":37},"2022-10-11",{"date":41,"type":21},"2027-08",{"name":43,"class":44},"Indiana University","OTHER"]